Medical News

News > Health > Medical News > J&J withdraws fibroid treatment device from market

J&J withdraws fibroid treatment device from market

WASHINGTON (AP) — Johnson & Johnson is asking surgeons not to use a line of devices for removing growths from the uterus amid regulators' growing concern that the electronic surgical tools raise the risk of spreading cancer to other parts of the body. In April, J&J suspended sales of the devices, known as laparoscopic power morcellators, after the Food and Drug Administration discouraged doctors from using them. Surgeons use the devices to treat painful fibroids, either by removing the growths themselves or the entire uterus. J&J said Wednesday it is conducting a worldwide withdrawal of all its morcellators still on the market. The company cited an FDA meeting earlier this month that reinforced "the complexity of this issue." FDA is weighing regulatory actions to reduce the risk of cancer spread.

Medical News

CHICAGO (AP) — Parents have increasingly pressured doctors to delay vaccines for young children, making their kids...
BOISE, Idaho (AP) — Ten-year-old Alexis Carey has a rare but intractable form of epilepsy, Dravet Syndrome. The...
BOISE, Idaho (AP) — Idaho lawmakers are considering legislation decriminalizing cannabis extract oil while not...
SALT LAKE CITY (AP) — A Salt Lake City-based company has agreed to pay refunds to consumers who purchased its...
SALEM, Ore. (AP) — Jennifer Margulis has her kids vaccinated and she gets shots herself. But she doesn't like the...